News & Updates

Topical gabapentin lessens itching in CKD patients

24 Jul 2020

Use of topical gabapentin in the short term helps ease pruritus in patients with chronic kidney disease (CKD), with no acute adverse effects, as shown in a study.

Topical gabapentin lessens itching in CKD patients

24 Jul 2020

Picosecond trumps Q-switched alexandrite laser in treatment of nevus of Ota

22 Jul 2020

A picosecond alexandrite laser (PSAL) appears to be superior to Q-switched alexandrite laser (QSAL) for the treatment of nevus of Ota, as shown by its better clinical results and fewer adverse events, according to a study.

Picosecond trumps Q-switched alexandrite laser in treatment of nevus of Ota

22 Jul 2020

Male sex, higher tumour grade tied to lower survival in cutaneous pleomorphic sarcoma

22 Jul 2020

Tumour size, grade, sex, race, and age at diagnosis are all associated with survival in patients with cutaneous pleomorphic sarcoma (CPS), suggests a study. Additionally, surgical tumour extirpation confers a survival benefit over no treatment, while primary or adjuvant radiation does not.

Male sex, higher tumour grade tied to lower survival in cutaneous pleomorphic sarcoma

22 Jul 2020

Cetirizine an attractive alternative to diphenhydramine for hives

21 Jul 2020 by

Cetirizine drip for treating acute urticaria is as effective as intravenous diphenhydramine, with the added benefits of less sedation, fewer adverse events, shorter treatment time, and lower rates of revisit to treatment centre, according to the results of a phase III study.

Cetirizine an attractive alternative to diphenhydramine for hives

21 Jul 2020

Clascoterone cream holds promise as alternative to traditional acne treatments

21 Jul 2020 by

Treatment with clascoterone cream 1% results in a favourable safety profile, with a low frequency of treatment-emergent adverse events (TEAEs) over 9 months, in patients with acne vulgaris, results of a recent study have shown.

Clascoterone cream holds promise as alternative to traditional acne treatments

21 Jul 2020

Two phase III trials support clinical benefit of anifrolumab in SLE

15 Jul 2020 by

The type I interferon receptor antibody anifrolumab reduced disease activity and flares in patients with moderate-to-severe active systemic lupus erythematosus (SLE), results of the TULIP-1 and TULIP-2 trials have shown.

Two phase III trials support clinical benefit of anifrolumab in SLE

15 Jul 2020

SELECT-PsA-1 demos upadacitinib benefits in psoriatic arthritis

08 Jul 2020 by

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

SELECT-PsA-1 demos upadacitinib benefits in psoriatic arthritis

08 Jul 2020

Biologics show promise in treatment of erythrodermic psoriasis

06 Jul 2020

Use of biologic medications to treat erythrodermic psoriasis (EP) is well-tolerated by and induces positive responses in patients, with a weak recommendation and limited quality of evidence in favour of infliximab, ustekinumab, ixekizumab, and guselkumab, a recent study has shown.

Biologics show promise in treatment of erythrodermic psoriasis

06 Jul 2020

Cell therapy with autologous DSC may help treat hair loss

06 Jul 2020

Autologous cell-based therapy using dermal sheath cup (DSC) appears to have beneficial effects for the treatment of male (MPHL) and female pattern hair loss (FPHL), suggest the results of a study.

Cell therapy with autologous DSC may help treat hair loss

06 Jul 2020

Ustekinumab, secukinumab trump other systemic drugs for psoriasis treatment

05 Jul 2020

A recent study has assessed the long-term safety of nine systemic medications for psoriasis, revealing the lowest incidence of adverse events with ustekinumab and secukinumab.

Ustekinumab, secukinumab trump other systemic drugs for psoriasis treatment

05 Jul 2020

News & Updates

Filter by Specialty:

Specialty:

Topical gabapentin lessens itching in CKD patients

Topical gabapentin lessens itching in CKD patients

Picosecond trumps Q-switched alexandrite laser in treatment of nevus of Ota

Picosecond trumps Q-switched alexandrite laser in treatment of nevus of Ota

Male sex, higher tumour grade tied to lower survival in cutaneous pleomorphic sarcoma

Male sex, higher tumour grade tied to lower survival in cutaneous pleomorphic sarcoma

Cetirizine an attractive alternative to diphenhydramine for hives

Cetirizine an attractive alternative to diphenhydramine for hives

Clascoterone cream holds promise as alternative to traditional acne treatments

Clascoterone cream holds promise as alternative to traditional acne treatments

Two phase III trials support clinical benefit of anifrolumab in SLE

Two phase III trials support clinical benefit of anifrolumab in SLE

SELECT-PsA-1 demos upadacitinib benefits in psoriatic arthritis

SELECT-PsA-1 demos upadacitinib benefits in psoriatic arthritis

Biologics show promise in treatment of erythrodermic psoriasis

Biologics show promise in treatment of erythrodermic psoriasis

Cell therapy with autologous DSC may help treat hair loss

Cell therapy with autologous DSC may help treat hair loss

Ustekinumab, secukinumab trump other systemic drugs for psoriasis treatment

Ustekinumab, secukinumab trump other systemic drugs for psoriasis treatment